Dyskinesia, Drug-InducedKartagener SyndromeDyskinesiasBiliary DyskinesiaLevodopaCiliary Motility DisordersAntiparkinson AgentsAxonemal DyneinsChoreaBenserazideMovement DisordersParkinsonian DisordersCiliaAntipsychotic AgentsParkinson DiseaseOxidopamineSitus InversusParkinson Disease, SecondaryAkathisia, Drug-InducedAxonemeCorpus StriatumCarbidopaDopamine AgentsEpilepsy, Benign NeonatalDyneinsMPTP PoisoningDopamine AgonistsSchizophreniaTranquilizing AgentsAdrenergic Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDystoniaBasal Ganglia DiseasesSerotonin 5-HT1 Receptor AgonistsMucociliary ClearancePhenothiazinesGlobus PallidusHaloperidolBronchiectasisAmantadineSubthalamic NucleusDynorphinsNasal CavityReceptor, Serotonin, 5-HT1ABenzothiazolesApomorphineReceptors, Dopamine D1CallithrixReceptors, Dopamine D3NeostriatumTropaeolaceae8-Hydroxy-2-(di-n-propylamino)tetralinReceptors, DopamineTiapamil HydrochlorideBasal GangliaMetoclopramideSubstantia NigraSerotonin AgentsAmishNeurologic ExaminationMedial Forebrain BundleNortropanesDopamineStereoisomerismSphincter of OddiMotor ActivityExomeSerotonin Receptor AgonistsDisease Models, AnimalPedigreeTetrabenazinePiribedilDopamine and cAMP-Regulated Phosphoprotein 32Stereotyped BehaviorReceptors, Dopamine D2Heterotaxy SyndromeAphakiaCommon Bile Duct DiseasesDeep Brain StimulationRisperidoneG-Protein-Coupled Receptor KinasesSperm TailSphincter of Oddi DysfunctionMagnetic Resonance SpectroscopyRats, Sprague-DawleyDose-Response Relationship, DrugRespiratory System5,7-DihydroxytryptamineNucleic Acid ConformationAdenosine A2 Receptor AntagonistsMacaca fascicularisParasympathomimeticsMutationBehavior, AnimalEntopeduncular NucleusPsychotic DisordersMolecular ConformationMolecular StructureTime FactorsCommunity Mental Health Centers